Angélique Da Silva

897 total citations · 1 hit paper
19 papers, 580 citations indexed

About

Angélique Da Silva is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Angélique Da Silva has authored 19 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Genetics and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Angélique Da Silva's work include Advanced Breast Cancer Therapies (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Treatment and Pharmacology (4 papers). Angélique Da Silva is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Treatment and Pharmacology (4 papers). Angélique Da Silva collaborates with scholars based in France, Netherlands and Belgium. Angélique Da Silva's co-authors include Joachim Alexandre, Charles Dolladille, Marion Sassier, Damien Legallois, Anne‐Flore Plane, Basile Chrétien, Sophie Fédrizzi, Véronique Lelong‐Boulouard, P Milliez and Stéphane Éderhy and has published in prestigious journals such as European Heart Journal, Frontiers in Pharmacology and BMJ Open.

In The Last Decade

Angélique Da Silva

17 papers receiving 576 citations

Hit Papers

Immune Checkpoint Inhibitor Rechallenge After Immune-Rela... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
    2020 377 citations Charles Dolladille, Stéphane Éderhy et al. JAMA Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angélique Da Silva France 7 451 176 98 86 51 19 580
Anne‐Flore Plane France 6 479 1.1× 168 1.0× 178 1.8× 99 1.2× 63 1.2× 13 656
Krishna S. Gunturu United States 12 343 0.8× 153 0.9× 87 0.9× 76 0.9× 77 1.5× 29 558
Sarah Skeoch United Kingdom 9 130 0.3× 239 1.4× 78 0.8× 143 1.7× 70 1.4× 19 631
Annachiara Mitrugno United States 14 328 0.7× 103 0.6× 76 0.8× 145 1.7× 184 3.6× 18 688
Sandip H. Patel United States 10 487 1.1× 246 1.4× 18 0.2× 91 1.1× 79 1.5× 31 611
Yu Miura Japan 17 570 1.3× 380 2.2× 37 0.4× 175 2.0× 72 1.4× 46 748
Yingyi Zhang China 10 114 0.3× 155 0.9× 88 0.9× 53 0.6× 117 2.3× 21 448
Bradley R. Corr United States 14 246 0.5× 85 0.5× 92 0.9× 89 1.0× 154 3.0× 64 699
Aya Nakaya Japan 13 290 0.6× 131 0.7× 18 0.2× 98 1.1× 102 2.0× 54 601
Rachele Amodeo Italy 9 95 0.2× 144 0.8× 49 0.5× 115 1.3× 77 1.5× 16 490

Countries citing papers authored by Angélique Da Silva

Since Specialization
Citations

This map shows the geographic impact of Angélique Da Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angélique Da Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angélique Da Silva more than expected).

Fields of papers citing papers by Angélique Da Silva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angélique Da Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angélique Da Silva. The network helps show where Angélique Da Silva may publish in the future.

Co-authorship network of co-authors of Angélique Da Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Angélique Da Silva. A scholar is included among the top collaborators of Angélique Da Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angélique Da Silva. Angélique Da Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chrétien, Basile, et al.. (2025). Guillain–Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study. Journal of Neurology. 273(1). 27–27.
2.
Morice, Alyn H., Pierre‐Marie Morice, Joachim Alexandre, et al.. (2025). Risk of thyroid cancer related to glucagon‐like peptide‐1 receptor agonists: A systematic review with meta‐analysis of harms of randomized controlled trials. Diabetes Obesity and Metabolism. 27(8). 4607–4610. 2 indexed citations
3.
Nishida, Kazuki, et al.. (2025). Pazopanib and antacids: insights from the WHO pharmacovigilance database. Cancer Chemotherapy and Pharmacology. 95(1). 66–66. 1 indexed citations
4.
5.
6.
7.
Silva, Angélique Da, et al.. (2024). Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer. Expert Opinion on Drug Metabolism & Toxicology. 20(1-2). 45–59. 5 indexed citations
8.
Chrétien, Basile, Perrine Brazo, Angélique Da Silva, et al.. (2023). Infections associated with clozapine: a pharmacovigilance study using VigiBase®. Frontiers in Pharmacology. 14. 1260915–1260915. 5 indexed citations
9.
Emile, George, Alison Johnson, Christelle Lévy, et al.. (2023). Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors. Frontiers in Oncology. 12. 1105587–1105587. 10 indexed citations
10.
Alexandre, Joachim, Pierre‐Marie Morice, Marion Sassier, et al.. (2023). Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials. JACC CardioOncology. 5(2). 216–226. 10 indexed citations
11.
Lequesne, Justine, Corinne Delcambre, Angélique Da Silva, et al.. (2023). Does COVID‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital. Cancer Medicine. 12(17). 17603–17612. 1 indexed citations
12.
Chrétien, Basile, Charles Dolladille, Angélique Da Silva, et al.. (2023). Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s database. Frontiers in Pharmacology. 14. 6 indexed citations
13.
Silva, Angélique Da, Alison Johnson, Cécile Blanc‐Fournier, et al.. (2022). HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer. BMC Cancer. 22(1). 1081–1081. 12 indexed citations
14.
Emile, George, et al.. (2021). Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib. Oncology Letters. 23(1). 25–25. 13 indexed citations
15.
Dolladille, Charles, Pierre‐Marie Morice, A. Dompmartin, et al.. (2021). Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis. European Heart Journal. 42(48). 4964–4977. 127 indexed citations
16.
Morice, Pierre‐Marie, Basile Chrétien, Angélique Da Silva, Charles Dolladille, & Joachim Alexandre. (2021). Occurrence of Pancytopenia Among Patients With Cancer Treated With Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors. JAMA Oncology. 7(12). 1899–1899. 4 indexed citations
17.
Silva, Angélique Da, Christelle Lévy, Djelila Allouache, et al.. (2020). Efficacy and Safety of Weekly Paclitaxel in Breast Cancer With Symptomatic Bone Marrow Infiltration. Anticancer Research. 40(5). 2955–2960. 1 indexed citations
18.
Dolladille, Charles, Stéphane Éderhy, Marion Sassier, et al.. (2020). Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer. JAMA Oncology. 6(6). 865–865. 377 indexed citations breakdown →
19.
Silva, Angélique Da, Basile Chrétien, Joachim Alexandre, & George Emile. (2020). Abemaciclib‐induced reversible grade 4 nephrotoxicity. The Breast Journal. 26(11). 2329–2330. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Flore Plane Breakdown of academic impact, for papers by Krishna S. Gunturu Breakdown of academic impact, for papers by Sarah Skeoch Breakdown of academic impact, for papers by Annachiara Mitrugno Breakdown of academic impact, for papers by Sandip H. Patel Breakdown of academic impact, for papers by Yu Miura Breakdown of academic impact, for papers by Yingyi Zhang Breakdown of academic impact, for papers by Bradley R. Corr Breakdown of academic impact, for papers by Aya Nakaya Breakdown of academic impact, for papers by Rachele Amodeo
Rankless by CCL
2026